ClearPoint Neuro
CLPT
17 hedge funds and large institutions have $3.4M invested in ClearPoint Neuro in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
4.79% more ownership
Funds ownership: 0% → 4.79% (+4.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1M |
| 2 |
Millennium Management
New York
|
+$472K |
| 3 |
Merriman Wealth Management
Seattle,
Washington
|
+$302K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$208K |
| 5 |
Kirr Marbach & Co
Columbus,
Indiana
|
+$177K |
Top Sellers
CLPT Hedge Fund Activity: Q3 2019 in Review
17 of the 4,576 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q3 2019, worth a combined $3.4M.
Buyers outnumbered sellers: 17 funds opened new CLPT positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $1M.
- 17 institutional investors held ClearPoint Neuro (CLPT) as of Q3 2019, up from 0 in Q2 2019.
- Funds reported $3.4M of ClearPoint Neuro stock for Q3 2019.
- 17 funds opened new ClearPoint Neuro positions in Q3 2019 and 0 closed out, a net change of +17 holders.
- The largest ClearPoint Neuro buyer in Q3 2019 was Vanguard Group, an estimated $1M added.
Based on aggregated 13F filings for Q3 2019.